Catalyst (CPRX) Rises as Q2 Earnings & Revenues Beat Estimates
CPRXCatalyst Pharmaceuticals(CPRX) ZACKS·2024-08-08 22:45

Catalyst Pharmaceuticals, Inc. (CPRX) reported adjusted earnings of 56 cents per share for the second quarter of 2024, beating the Zacks Consensus Estimate of 42 cents. The company reported adjusted earnings of 53 cents in the year-ago quarter.Total revenues, the majority of which comprised product revenues, amounted to 122.7millioninthereportedquarter,representinggrowthof23122.7 million in the reported quarter, representing growth of 23% year over year. The recorded figure also surpassed the Zacks Consensus Estimate of 111.6 million.Catalyst’s top line prima ...